Type 3 von Willebrand disease: Assessment of complications and approaches to treatment - Results of a patient and Hemophilia Treatment Center survey in the United States

Haemophilia

Volumn 10, Issue 4, 2004, Pages 360-366

  Sumner, Mike ^a   Williams, J ^a  

^a Aventis Behring   (United States)

Author keywords

Survey; Treatment; Type 3; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; KOATE DVI;

ABSENTEEISM; ADULT; ARTICLE; BLEEDING; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; EPISTAXIS; FEMALE; FINANCIAL MANAGEMENT; GINGIVA BLEEDING; HEMARTHROSIS; HUMAN; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MENSTRUATION DISORDER; MORBIDITY; NURSE; POSTAL MAIL; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES; VON WILLEBRAND DISEASE;

EID: 4043150020     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00903.x     Document Type: Article

References (12)

1. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Prac Res Clin Hematol 2001; 14: 257-79.
2. Miller CH, Lenzi R, Breen C. Prevalence of VWD among US adults. Blood 1987; 70 (Suppl. 1): 377.
3. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of VWD in children: a multiethnic study. J Pediatr 1993; 123: 893-8.
4. Sadler JE, Mannucci PM, Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
5. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 74: 520-5
6. Tuddenham EG. von Villebrand factor and its disorders: an overview of recent molecular studies. Blood Rev 1989; 3: 251-62.
7. Lenk H, Nilsson IM, Holmberg L, Weissbach G. Frequency of different types of VWD in the GDR. Acta Med Scand 1988; 224: 275-80.
8. Awidi AS. A study of VWD in Jordan. Ann Hematol 1992; 64: 299-302.
9. Berliner SA, Seligson U, Zivelin A, Zwang E, Sofferman G. A relative high frequency of severe (type 3) VWD in Israel. Br J Haematol 1986; 62: 535-43.
10. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8: 607-21.
11. Berntorp E. Prophylaxis for hemophilia. Int J Pediatric Hematol Oncol 1994; 1: 463-70.
12. Cohen AJ, Kessler CM, Ewenstein BM. Management of von Willebrand disease: a survey on current practice from the hemophilia centres of North America. Hemophilia 2001; 7: 235-41.